Pressavein tablets – Anti-platelet

Composition

• Pressavein 50 mg. tablets: each tablets contains Dipyridamole 50 mg.
• Pressavein 75 mg. tablets: each tablets contains Dipyridamole 75 mg.

Indicaions

• All forms of coronary insufficiency.
• Acute myocardial infraction with circulatory collapse.
• Cardiac failure, long term treatment of chronic angina pectoris.
• Antithrombotic (combined with aspirin and warfarin) for prevention of occlusive arterisclerosis and atherothrombo-cerebral infarction.
• To inhibit embolization from prosthetic heart valves.

Contra-indications

• Hypersensitivity to dipyridamole.
• Haemodynamic instability following myocardial infraction.
• Severe hypotension.
• Impaired liver functions.
• Must be taken with care under strict medical supervision during pregnancy especially the first trimester (although studies proved its safety on the foetus).

Dosage

• In chronic angina pectoris and cardiac insufficiency one tablet ( 50-75 mg.) 3 Times daily before meals.
• For modification of platelet functions: 100 mg. 4 times daily before meals.

Package

• Pressavein 50 mg. tablets: pack of 30 tablets and 1000 tablets
• Pressavein. 75 mg. tablets: Pack of 30 tablets and 1000 tablets

Storage

• Store at temperature not exceeding 30°C.
• Keep in dry place, protect from light.
• Keep out of reach of children.

Medicament is a product which affects your health, and its consumption contrary to instructions is dangerous for you. Follow strictly the doctor’s prescription, the method of use and the instructions of the pharmacist who sales the medicament. The doctor and the pharmacist are experts in medicine. It’s benefits and risks. Do not by yourself interrupt the period of treatment prescribed for you. Do not repeat the same prescription without consulting your doctor. Keep medicament out of children reach. Council of Arab Health Ministers and Union of Arab Pharmacists

Produced by: El Nasr Pharmaceutical Chemicals Co. “ADWIC” Abu-Zaabal – A.R.E.. ATC Code: B01AC07